Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04842266 · ClinicalTrials.gov registry record
IlluminOss Photodynamic Bone Stabilization System for the Treatment of Impending and Actual Pelvis Fractures
A clinical trial of Trauma and Cancer Metastatic, sponsored by Massachusetts General Hospital.
- Recruiting
- Registry status
- 100
- Enrollment target
- 1
- Study location
NCT04842266: Recruiting study of Trauma and Cancer Metastatic, sponsored by Massachusetts General Hospital.
NCT04842266 is a study of Trauma and Cancer Metastatic that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 100 participants, below the 306-participant average among 56 other Trauma trials with a reported enrollment target (67% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04842266, a study of Trauma and Cancer Metastatic, is actively recruiting participants, sponsored by Massachusetts General Hospital.
- RECRUITING
- Registry status
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The aim of this project is to assess the effectiveness of the IlluminOss pelvic implants in patients with pelvic metastatic disease presenting with pain, risk of pathologic fracture, non-displaced or minimally displaced pathologic fracture of the pelvis, and geriatric patients with pelvic fragility fractures. Results from this study will be used to confirm preliminary clinically and possibly statistically significant reductions in pain and improvements in function among these patients.
Primary Outcome
Patients treated with the IlluminOss pelvic implant will be given functional and pain surveys pre-operatively (within 2 weeks before surgery) and post-operatively (at 2 days, 2 weeks, 6 weeks, 3 months, 6 months, 1 year, and 2 years). 100 patients will be included in the study. The surveys include the VAS Pain, the EQ-VAS, the Combined Pain and Ambulatory Function, the PROMIS Pain Inteference, and the PROMIS Physical Function. Additionally, the MSTS survey will be collected for oncologic patient
Conditions Studied
Interventions
- DEVICE IlluminOss pelvic implant for oncologic indication
- DEVICE IlluminOss pelvic implant for geriatric trauma indication
Study Locations (1)
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2021-11-18 |
| Est. Completion | 2027-12 |
What NCT04842266 shows while recruiting
NCT04842266 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 306-participant average among 56 other Trauma trials with a reported enrollment target (67% lower).
The record links to 3 conditions, with Trauma appearing as the primary indexed condition, and to 2 interventions - of which IlluminOss pelvic implant for oncologic indication is the first listed.
NCT04842266 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT04842266 about?
NCT04842266 is a clinical study titled "IlluminOss Photodynamic Bone Stabilization System for the Treatment of Impending and Actual Pelvis Fractures". The aim of this project is to assess the effectiveness of the IlluminOss pelvic implants in patients with pelvic metastatic disease presenting with pain, risk of pathologic fracture, non-displaced or minimally displaced pathologic fracture of the pelvis, and geriatric patients with pelvic fragility ...
What is the current status of trial NCT04842266?
This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2021-11-18. Estimated completion is 2027-12.
What conditions does trial NCT04842266 study?
This clinical trial studies the following conditions: Trauma, Cancer Metastatic, Pathologic Fracture.
What interventions are being tested in trial NCT04842266?
The interventions under investigation include: IlluminOss pelvic implant for oncologic indication (DEVICE), IlluminOss pelvic implant for geriatric trauma indication (DEVICE).
Who is sponsoring clinical trial NCT04842266?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04842266 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Trauma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04842266's enrollment target sits among peer trials
100 31st of 56 higher than 25 of 56 other Trauma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Trauma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
CAlcium and VAsopressin Following Injury Early Resuscitation (CAVALIER) Trial
RECRUITING · Phase 2
-
Testing FIRST in Youth Outpatient Psychotherapy
RECRUITING · NA
-
PRESERVE & CONNECT: Impact Study of the BPC
RECRUITING · NA
-
Multiphase Optimization Strategy (MOST) for Treating Pediatric Post-traumatic Stress Disorder (PTSD)
RECRUITING · NA
-
PMCF Study to Evaluate the VERTICALE® Cervical System in Spine Surgery According to Its Intended Use.
RECRUITING
-
Evaluation of the Parenting in the Moment Online Program for Forcibly Displaced Families
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI